Aims: To investigate the present attitude of the Italian Radiation Oncologists in the management of breast cancer (BC) concerning hypofractionated radiotherapy (hRT), partial-breast irradiation (PBI), re-irradiation (rRT) and radiotherapy after neoadjuvant chemotherapy (post-NAC RT). Methods: A nationwide, 21-point questionnaire was distributed online via SurveyMonkey. Results: Seventy-four Italian Radiotherapy Centers answered to the survey. In most cases, the responding centers treated more than 100 BC patients/year between January 2016 and December 2017. Almost half of responding centers (49%) treated patients with hRT,out of these, 95% as routine practice for early-stage BC. Dose prescriptions ranged between 39 and 45 Gy indicating a high use of moderate hRT. The chest wall and regional lymph nodes were irradiated with hRT by 13% and 15% of the responding centers, respectively. PBI was used by 60% of responders, with different techniques. Only 0.6% of participants perform rRT after BC recurrence.Finally, only 11% of the interviewed centers responded to their attitude toward post-NAC RT, which, however, was indicated in 97% of patients after breast-conserving surgery. Conclusions: This survey shows a fairly good use of hRT and a moderate practice of PBI in Italy. Some practices like hRT to the chest wall and regional lymph nodes as well as rRT need further verification. Likewise, the management of post-NAC RT is very heterogeneous. Future national clinical collaborative studies are advocated in order to investigate these controversial topics about breast cancer radiotherapy.

Present clinical practice of breast cancer radiotherapy in Italy: a nationwide survey by the Italian Society of Radiotherapy and Clinical Oncology (AIRO) Breast Group / Gregucci F.; Fozza A.; Falivene S.; Smaniotto D.; Morra A.; Daidone A.; Barbara R.; Ciabattoni A.; Andrulli D.; Arcidiacono F.; Baiocchi C.; Baldissera A.; Barbarino R.; Bartoncini S.; Bono M.; Buffoli A.; Campanella B.; Campoccia S.; Catalano G.; Cavallari M.; Cerreta V.; Ciabattoni A.; Daidone A.; Deantonio L.; De Rose F.; Del Bufalo S.; Digennaro D.; Doino D.; Evangelista G.; Falivene S.; Fedele F.; Fiorentino A.; Fodor A.; Fontana A.; Fozza A.; Fusco V.; Gatti M.; Gerardi M.; Giannini M.; Girlando A.; Guenzi M.; Guida C.; Huscher A.; Iannone T.; Iorio V.; Ippolito E.; Ivaldi G.; La Porta M.; Lazzari G.; Lioce M.; Lora O.; Macchia G.; Mangiacotti M.G.; Marafioti L.; Marino L.; Marmiroli L.; Maucieri A.; Maurizi F.; Mazzuoli L.; Meattini I.; Meduri B.; Montesi G.; Morra A.; Munoz F.; Nuzzo M.; Orru S.; Parisi S.; Pasinetti N.; Pedretti S.; Perrucci E.; Piva D.; Prisco A.; Ravo V.; Santacaterina A.; Scolaro T.; Serafini F.; Spigone B.; Tolento G.; Vidali C.; Vitucci P.; Zini G.. - In: LA RADIOLOGIA MEDICA. - ISSN 0033-8362. - ELETTRONICO. - 125:(2020), pp. 674-682. [10.1007/s11547-020-01147-5]

Present clinical practice of breast cancer radiotherapy in Italy: a nationwide survey by the Italian Society of Radiotherapy and Clinical Oncology (AIRO) Breast Group

Meattini I.;
2020

Abstract

Aims: To investigate the present attitude of the Italian Radiation Oncologists in the management of breast cancer (BC) concerning hypofractionated radiotherapy (hRT), partial-breast irradiation (PBI), re-irradiation (rRT) and radiotherapy after neoadjuvant chemotherapy (post-NAC RT). Methods: A nationwide, 21-point questionnaire was distributed online via SurveyMonkey. Results: Seventy-four Italian Radiotherapy Centers answered to the survey. In most cases, the responding centers treated more than 100 BC patients/year between January 2016 and December 2017. Almost half of responding centers (49%) treated patients with hRT,out of these, 95% as routine practice for early-stage BC. Dose prescriptions ranged between 39 and 45 Gy indicating a high use of moderate hRT. The chest wall and regional lymph nodes were irradiated with hRT by 13% and 15% of the responding centers, respectively. PBI was used by 60% of responders, with different techniques. Only 0.6% of participants perform rRT after BC recurrence.Finally, only 11% of the interviewed centers responded to their attitude toward post-NAC RT, which, however, was indicated in 97% of patients after breast-conserving surgery. Conclusions: This survey shows a fairly good use of hRT and a moderate practice of PBI in Italy. Some practices like hRT to the chest wall and regional lymph nodes as well as rRT need further verification. Likewise, the management of post-NAC RT is very heterogeneous. Future national clinical collaborative studies are advocated in order to investigate these controversial topics about breast cancer radiotherapy.
2020
125
674
682
Gregucci F.; Fozza A.; Falivene S.; Smaniotto D.; Morra A.; Daidone A.; Barbara R.; Ciabattoni A.; Andrulli D.; Arcidiacono F.; Baiocchi C.; Baldissera A.; Barbarino R.; Bartoncini S.; Bono M.; Buffoli A.; Campanella B.; Campoccia S.; Catalano G.; Cavallari M.; Cerreta V.; Ciabattoni A.; Daidone A.; Deantonio L.; De Rose F.; Del Bufalo S.; Digennaro D.; Doino D.; Evangelista G.; Falivene S.; Fedele F.; Fiorentino A.; Fodor A.; Fontana A.; Fozza A.; Fusco V.; Gatti M.; Gerardi M.; Giannini M.; Girlando A.; Guenzi M.; Guida C.; Huscher A.; Iannone T.; Iorio V.; Ippolito E.; Ivaldi G.; La Porta M.; Lazzari G.; Lioce M.; Lora O.; Macchia G.; Mangiacotti M.G.; Marafioti L.; Marino L.; Marmiroli L.; Maucieri A.; Maurizi F.; Mazzuoli L.; Meattini I.; Meduri B.; Montesi G.; Morra A.; Munoz F.; Nuzzo M.; Orru S.; Parisi S.; Pasinetti N.; Pedretti S.; Perrucci E.; Piva D.; Prisco A.; Ravo V.; Santacaterina A.; Scolaro T.; Serafini F.; Spigone B.; Tolento G.; Vidali C.; Vitucci P.; Zini G.
File in questo prodotto:
File Dimensione Formato  
2020_Radiol Medica_Gregucci2020_Article_PresentClinicalPracticeOfBreas.pdf

Accesso chiuso

Tipologia: Pdf editoriale (Version of record)
Licenza: Tutti i diritti riservati
Dimensione 597.96 kB
Formato Adobe PDF
597.96 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1259023
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 28
  • ???jsp.display-item.citation.isi??? 27
social impact